Sun yat-sen university cancer cencer
Sun yat-sen university cancer cencer
Guangzhou, Guangdong, China1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Sintilimab Plus Rituximab Followed by R-CHOP Regimen in Untreated PMBL | Primary Mediastinal Diffuse Large B-cell Lymphoma | Recruiting | Phase 2 | 2025-06-05 | NCT06742502 |